Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis
about
Purinergic Signaling to Terminate TLR Responses in MacrophagesAnti-inflammatory therapy in chronic disease: challenges and opportunitiesAdenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient miceData on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response.Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient miceRegulation of foam cells by adenosine.DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis.A2b adenosine receptor regulates hyperlipidemia and atherosclerosisGuidelines for assessing mouse endothelial function via ultrasound imaging: a report from the International Society Of Cardiovascular Translational Research.An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.Regulation of macrophage function by adenosine.Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors.Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism.A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.Adenosine and blood platelets.Targeting adenosine receptors in the development of cardiovascular therapeutics.A2 adenosine receptors and vascular pathologies.Molecular biology of atherosclerosis.Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridinesFlank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway.CD73 regulates vascular smooth muscle cell functions and facilitates atherosclerotic plaque formation.Bone Marrow-Derived MicroRNA-223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease.Inactivation of adenosine A2A receptor attenuates basal and angiotensin II-induced ROS production by Nox2 in endothelial cells.Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis.
P2860
Q26765923-CF6CAEEB-0E59-4890-875B-5F017E5284B0Q26860162-E8D9D172-A352-4BA7-8C28-B6C88B3DDD11Q30432457-B1808FA5-A49C-45BD-B098-51399955F1B5Q31124912-7D35F52B-E71B-45F9-BCF2-6DF84944D7CDQ33662075-4F02A0AA-F406-4F8F-A995-2DD0C7985F28Q33867669-4B6C6AAF-0A6D-48B0-B75D-C276756C7426Q34031160-960C460D-EC7B-4091-B48E-BBDDFD0A7B4AQ35048434-CD718462-91A5-40A3-847B-4EF1D9AA6F2FQ35694128-9649C676-69B5-4E97-84FB-69E2AC183B7FQ35838375-F6EEB7DE-AB79-49A8-A685-AAC52878D317Q35838389-13F0075C-022A-43FD-8EA8-1436A864E03AQ36070200-36CE0FE5-606F-45C0-98D8-BCC509F36F95Q37137878-6AC52E0C-CA14-43AC-BA82-00B6285B3726Q37360635-54A42176-EBA6-49F0-9D9A-645810014E02Q37644773-34B139C3-9A17-41EC-9AAE-04BEF8E5B0CBQ37864112-DD528C78-BEF8-4628-813F-B330FBC80471Q37990558-AABD98ED-E5B5-4F54-8DC4-960C0EE09085Q37994174-8BA82F18-F9A5-4CF2-ABF5-AA907A00D9AAQ38125279-17C34FDA-C0A3-4BE6-875A-29C1EF328243Q38694069-CEC4DCE3-E4C8-49FE-8F4C-9C0677189352Q39069360-80DEFC9D-FEE0-4F1B-B97D-944D99B6AE55Q39849688-D0FEC90D-34F8-46E6-AC57-EE892C8869A9Q40387157-D4683DDC-B032-4E52-92AE-D2CA26B36478Q41102553-5BE22247-45F8-49CB-8A66-9F22C522F4EAQ41130750-891E0452-3572-4E63-A689-2F28342AEE98Q46282086-EB28933D-57C3-44D5-A561-31EF0F1ECA0DQ51376719-111162EB-426D-4345-8AF2-3B5356D86CBFQ52656382-ADEAA98C-C02B-4638-87FB-F1CEDF944685Q54270774-15884D62-D3F4-4273-9192-3640E3FB54DC
P2860
Inactivation of the adenosine A2A receptor protects apolipoprotein E-deficient mice from atherosclerosis
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inactivation of the adenosine ...... ient mice from atherosclerosis
@ast
Inactivation of the adenosine ...... ient mice from atherosclerosis
@en
type
label
Inactivation of the adenosine ...... ient mice from atherosclerosis
@ast
Inactivation of the adenosine ...... ient mice from atherosclerosis
@en
prefLabel
Inactivation of the adenosine ...... ient mice from atherosclerosis
@ast
Inactivation of the adenosine ...... ient mice from atherosclerosis
@en
P2093
P2860
P1476
Inactivation of the adenosine ...... ient mice from atherosclerosis
@en
P2093
Bruce R Blazar
Chaodong Wu
Christoph Bucher
Chuhong Zhu
Chunxiang Zhang
Jiang-Fan Chen
Joel Linden
Weiyu Zhang
Yuqing Huo
P2860
P304
P356
10.1161/ATVBAHA.109.188839
P407
P577
2009-04-30T00:00:00Z